Contracted Management Consulting Services from a Medical Corporation in Tokyo
～Supporting Smooth Business Succession of Clinics and Hospitals that worry the successors～

TOKYO, Japan - December 26, 2019 - ORIX Corporation (“ORIX”) announced that it has received a contract for management consulting from Junseikai, a medical corporation that operates a clinic in Tokyo. ORIX's consolidated subsidiary, CMC Corporation¹, which provides management support services for medical institutions, formulates business plans and financing plans to support the sustainable management of Junseikai.

Junseikai is a medical corporation that has been operating “Hirooka Clinic” for 26 years. Along with providing outpatient clinics for internal medicine, pediatrics, surgery, etc., Junseikai is also focusing on preventive medical care, such as actively accepting company medical examinations and medical checkups at the attached medical examination center.

CMC, in addition to management consulting services to medical institutions, is entrusted with administrative tasks such as the payroll calculations and sales operations such as guidance of medical checkups to client companies. With the retirement of Yasumasa Hirooka, the founder and chairman of Junseikai, CMC has been entrusted each task from Junseikai and supported the smooth succession of business, creating an environment where Junseikai could concentrate on medical management.

According to the Ministry of Health, Labour and Welfare, approximately half of the doctors working in the clinics are over 60 years old and continue to age². ORIX conducts a wide range of businesses in the medical field, such as leasing and financing for medical corporations and rental services for CT/MRI-equipped vehicles, in addition to administrative outsourcing services by the CMC. ORIX provides support for the management of medical institutions by leveraging its financial services know-how and business promotion capabilities.

ORIX will continue to contribute to the development of preventive medical care and regional healthcare in Japan by expanding alliances with clinics and hospitals that worry the successors, and by providing support to stabilize management.

¹　July 3^rd, 2017 Press Release: ORIX begins capital tie-ups with business support service company for medical institutions
²　From the general conditions of doctors, dentists and pharmacist’s investigation in 2018

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses.
Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into lending, investment, life insurance, banking, asset management, automobile related, real estate and environment and energy related businesses. Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 37 countries and regions across the world.
Going forward, ORIX intends to utilize its strengths and expertise, which generate new value, to establish an independent ORIX business model that continues to evolve perpetually. In this way, ORIX will engage in business activities that instill vitality in its companies and workforce, and thereby contribute to society. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2019)

Caution Concerning Forward Looking Statements:
These documents May contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2018 – March 31, 2019.”